iShares Bitcoin Trust vs DENTSPLY SIRONA Inc — how do they compare? iShares Bitcoin Trust trades at $46.92 (market cap $67.31B), while DENTSPLY SIRONA Inc trades at $8.8 (market cap $1.73B). The key difference: iShares Bitcoin Trust is far larger — about 38.9× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while iShares Bitcoin Trust pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares Bitcoin Trust for 40 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| IBIT | XRAY | |
|---|---|---|
Market Cap | $67.31B | $1.73B |
Volume | 56,154,544 | 6,198,582 |
Sector | Crypto-linked | Health |
52-Week High | $68.74 | $14.68 |
52-Week Low | $33.29 | $8.52 |
Typical Hold Time | 40 Days | 72 Days |
Enterprise Value | — | $3.80B |
Dividend Yield | — | 5.04% |
Signals from Pluang's Aura AI — not financial advice
IBIT trades at $46.76, down 0.95% on the day, with technical indicators showing mixed signals. The overall technical outlook is bearish despite moving averages suggesting some bullish momentum. Recent news highlights significant institutional interest with BlackRock's IBIT recording $196 million in daily inflows (24/7 Wall Street, 2026-10-04). The stock faces pressure from oscillators but maintains key support levels at $44-$46.
The outlook remains cautious with institutional inflows providing support, but technical weakness and lack of fundamental data create uncertainty. Investment opportunities exist if technical support holds, while risks include market volatility and dependency on broader Bitcoin ETF trends. Investors should monitor institutional flow data and technical breakouts for directional cues.
DENTSPLY SIRONA (XRAY) trades at $8.54, near its 52-week low, with bearish technical indicators and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating expectations but revenue declined 4.1% year-over-year. Net income remains negative at -$598 million for 2025, though margins show slight improvement. Analyst consensus is mixed with 37.5% buy ratings but a $13.40 price target suggesting 57% upside potential from current levels.
The stock presents a high-risk turnaround opportunity with significant upside if management's restructuring efforts succeed, but faces headwinds from declining sales, margin pressure, and competitive challenges in dental markets. Institutional ownership changes and ongoing transformation investments create both uncertainty and potential for recovery.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →